We are live on ! Find out more
YF

Yu Fan Portfolio holdings

AUM $108M
1-Year Est. Return 137.54%
This Fund
S&P 500
This Quarter Est. Return
+31.46%
1 Year Est. Return
+137.54%
3 Year Est. Return
+42.74%
5 Year Est. Return
-38.65%
10 Year Est. Return
AUM
$7.47M
AUM Growth
+$128K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 67.73%
2 Healthcare 31.6%
3 Consumer Staples 0.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABGI
1
DELISTED
ABG Acquisition Corp. I
ABGI
$5.06M 67.73%
501,300
SONX
2
DELISTED
Sonendo, Inc.
SONX
$1.55M 20.76%
547,945
CSTL icon
3
Castle Biosciences
CSTL
$1.05B
$485K 6.49%
20,592
APGN
4
DELISTED
Apexigen, Inc. Common Stock
APGN
$274K 3.67%
401,757
SYRE icon
5
Spyre Therapeutics
SYRE
$8.25B
$50.4K 0.68%
4,482
PRE icon
6
Prenetics Global
PRE
$440M
$50K 0.67%
1,667

Similar funds

Yu Fan's Q4 2022 Portfolio in Review

As of Q4 2022, Yu Fan held 6 positions worth $7.47M, up 1.7% from $7.34M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Yu Fan opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 68% of assets, down from 68% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Yu Fan's ten largest holdings make up 100% of its $7.47M portfolio in Q4 2022.
  • Yu Fan opened 0 new positions and closed 0 in Q4 2022.
  • Yu Fan's portfolio value rose 1.7% quarter-over-quarter to $7.47M.

Based on Yu Fan's 13F filing for Q4 2022, filed 14 Feb 2023.